chr19-55159274-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_001256715.2(DNAAF3):​c.1414G>A​(p.Gly472Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G472E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00024 ( 0 hom. )

Consequence

DNAAF3
NM_001256715.2 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.88

Publications

6 publications found
Variant links:
Genes affected
DNAAF3 (HGNC:30492): (dynein axonemal assembly factor 3) The protein encoded by this gene is required for the assembly of axonemal inner and outer dynein arms and plays a role in assembling dynein complexes for transport into cilia. Defects in this gene are a cause of primary ciliary dyskinesia type 2 (CILD2). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
DNAAF3-AS1 (HGNC:55292): (DNAAF3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0143066645).
BP6
Variant 19-55159274-C-T is Benign according to our data. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208. Variant chr19-55159274-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 330208.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000302 (46/152308) while in subpopulation AMR AF = 0.000849 (13/15306). AF 95% confidence interval is 0.000502. There are 0 homozygotes in GnomAd4. There are 25 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAAF3NM_001256715.2 linkc.1414G>A p.Gly472Arg missense_variant Exon 12 of 12 ENST00000524407.7 NP_001243644.1 Q8N9W5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAAF3ENST00000524407.7 linkc.1414G>A p.Gly472Arg missense_variant Exon 12 of 12 1 NM_001256715.2 ENSP00000432046.3 Q8N9W5-1
ENSG00000267110ENST00000587871.1 linkn.397G>A non_coding_transcript_exon_variant Exon 4 of 9 5 ENSP00000473050.1 M0R381

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
46
AN:
152190
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000850
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000357
AC:
89
AN:
249208
AF XY:
0.000377
show subpopulations
Gnomad AFR exome
AF:
0.0000647
Gnomad AMR exome
AF:
0.000696
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.0000464
Gnomad NFE exome
AF:
0.000469
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000240
AC:
351
AN:
1461728
Hom.:
0
Cov.:
31
AF XY:
0.000254
AC XY:
185
AN XY:
727172
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.000805
AC:
36
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000197
AC:
17
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53268
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.000230
AC:
256
AN:
1112006
Other (OTH)
AF:
0.000431
AC:
26
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152308
Hom.:
0
Cov.:
33
AF XY:
0.000336
AC XY:
25
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41566
American (AMR)
AF:
0.000849
AC:
13
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68026
Other (OTH)
AF:
0.00237
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000436
Hom.:
0
Bravo
AF:
0.000416
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000241
AC:
2
ExAC
AF:
0.000372
AC:
45
EpiCase
AF:
0.000654
EpiControl
AF:
0.000711

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia Uncertain:1Benign:1
Apr 16, 2025
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Sep 01, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 539 of the DNAAF3 protein (p.Gly539Arg). This variant is present in population databases (rs201919395, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with DNAAF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 330208). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.2
DANN
Benign
0.52
DEOGEN2
Benign
0.0023
.;T;.;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.016
N
LIST_S2
Benign
0.50
T;T;T;T
M_CAP
Benign
0.0028
T
MetaRNN
Benign
0.014
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
.;N;.;.
PhyloP100
-1.9
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.060
N;.;.;N
REVEL
Benign
0.068
Sift
Benign
0.23
T;.;.;T
Sift4G
Benign
0.69
T;T;T;T
Polyphen
0.0070
.;B;.;.
Vest4
0.066
MutPred
0.32
.;Gain of loop (P = 0.0321);.;.;
MVP
0.030
MPC
0.28
ClinPred
0.010
T
GERP RS
-7.0
Varity_R
0.047
gMVP
0.35
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201919395; hg19: chr19-55670642; API